Billionaires Holding CMRX

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 36.5M
    Shares Outstanding

  • 187.62M
    Market Cap

News & Insights

ABOUT

CMRX

Chimerix, Inc. is a biopharmaceutical discovers and commercializes oral antiviral therapeutics. The Company develops novel antiviral therapeutics with the potential to transform patient care in multiple settings including transplant, oncology, acute care, and global health. Chimerix operates in t...

Google parent Alphabet's earnings: $8.42 per share, vs expected EPS of $8.04

NEWS

Amazon keeps its crown as king of cloud as sales pop

READ MORE